NAD+ regulates nucleotide metabolism and genomic DNA replication

The intricate orchestration of enzymatic activities involving nicotinamide adenine dinucleotide (NAD+) is essential for maintaining metabolic homeostasis and preserving genomic integrity. As a co-enzyme, NAD+ plays a key role in regulating metabolic pathways, such as glycolysis and Kreb’s cycle. ADP-ribosyltransferases (PARPs) and sirtuins rely on NAD+ to mediate post-translational modifications of target proteins. The activation of PARP1 in response to DNA breaks leads to rapid depletion of cellular NAD+ compromising cell viability. Therefore, the levels of NAD+ must be tightly regulated. Here we show that exogenous NAD+, but not its precursors, has a direct effect on mitochondrial activity. Short-term incubation with NAD+ boosts Kreb’s cycle and the electron transport chain and enhances pyrimidine biosynthesis. Extended incubation with NAD+ results in depletion of pyrimidines, accumulation of purines, activation of the replication stress response and cell cycle arrest. Moreover, a combination of NAD+ and 5-fluorouridine selectively kills cancer cells that rely on de novo pyrimidine synthesis. We propose an integrated model of how NAD+ regulates nucleotide metabolism, with relevance to healthspan, ageing and cancer therapy.


Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.

n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.

A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g.means) or other basic estimates (e.g.regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g.confidence intervals) For null hypothesis testing, the test statistic (e.g.F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g.Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection Zeiss ZEN (v3.2 blue edition) software, for LSM microscope image acquisition Olympus scanR 3.3 software, for QIBC image acquisition BD FACSuite V1.0.6 software, for flow cytometry data acquisition MinKNOW (v20.06.4), for RNAseq data acquisition Validation Rat anti-BrdU antibody, validated by the company and cited in 284 research publications Mouse anti-BrdU antibody, monoclonal antibody originally described in Science 1982; 218:474, validated by the company and cited in 1036 research publications DyLight 550, validated by the company Alexa Fluor 488 (Invitrogen, A21202), validated by the company Alexa Fluor 488 (Invitrogen, A11029), validated by the company Fibrillarin, validated by the company and cited in 158 research publications p-CHK1 S317, validated by the company and cited in 243 research publications CHK1, validated by the company and cited in 789 research publications p-CHK2 T68, validated by the company and cited in 19 research publications CHK2, knockout validated by the company and cited in 17 research publications p-H2A.X S139 (γH2AX), validated by the company and cited in 131 research publications β-Actin, validated by the company and cited in nearly 4000 research publications p-AMPKα T172, validated by the company and cited in 2954 research publications AMPKα, validated by the company and cited in 428 research publications p-mTOR S2481, validated by the company and cited in 376 research publications mTOR, validated by the company and cited in 1605 research publications α-Tubulin, validated by the company and cited in 122 research publications SLC25A51/MCART1, validated by the company and cited in Sci.Adv.2020; 6 : eabe5310.Vinculin, validated by the company (enhanced-validation strategy) and cited in 1937 research publications VDAC, validated by the company and cited in 298 research publications COX IV, validated by the company and cited in 124 research publications OPA1, validated by the company and cited in 52 research publications ATPB, validated by the company and cited in 229 research publications Horseradish peroxidase-conjugated anti-rabbit secondary antibody, validated by the company and cited in 659 research publications Horseradish peroxidase-conjugated anti-mouse secondary antibody, validated by the company and cited in 428 research publications